Form 4 Tracker
Moderna, Inc.
MRNA

53 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Nov 29, 2024Nov 29 8:35 PMMock James M
Proposed Sale
1,420$42.79$60.8K—

View →

Nov 11, 2024Nov 12 2:27 PMHoge Stephen
Proposed Sale
277$46.10$12.8K—

View →

Oct 7, 2024Oct 7 7:20 PMMock James M
Proposed Sale
715$60.12$43.0K—

View →

Sep 9, 2024Sep 9 7:29 PMKlinger Shannon Thyme
Proposed Sale
551$73.57$40.5K—

View →

Sep 3, 2024Sep 3 7:58 PMKlinger Shannon Thyme
Proposed Sale
114$76.99$8.8K—

View →

Sep 3, 2024Sep 3 7:42 PMHoge Stephen
Proposed Sale
318$76.99$24.5K—

View →

Aug 29, 2024Aug 29 7:52 PMKlinger Shannon Thyme
Proposed Sale
162$78.03$12.6K—

View →

Aug 29, 2024Aug 29 7:43 PMMock James M
Proposed Sale
162$78.03$12.6K—

View →

Aug 29, 2024Aug 29 7:38 PMHoge Stephen
Proposed Sale
300$78.03$23.4K—

View →

Aug 28, 2024Aug 28 8:47 PMMock James M
Proposed Sale
1,321$79.39$104.9K—

View →

Aug 28, 2024Aug 28 8:30 PMKlinger Shannon Thyme
Proposed Sale
1,319$79.39$104.7K—

View →

← Previous

Page 3 of 3

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 6, 2026May 8 9:04 PMSandra HorningDirector
Grant/Award
11,773$48.792,092(D)

View →

May 6, 2026May 8 9:02 PMElizabeth G NabelDirector
Grant/Award
8,371—8,371(D)

View →

May 6, 2026May 8 8:59 PMFrancois NaderDirector
Grant/Award
10,639$48.794,185(D)

View →

May 6, 2026May 8 8:57 PMElizabeth E TallettDirector
Grant/Award
8,371—8,371(D)

View →

May 6, 2026May 8 8:54 PMNoubar AfeyanDirector
Grant/Award
12,908$48.7912,908(D)

View →

Apr 30, 2026May 4 9:39 PMSandra HorningDirector
Option Exercise
16,233—0(D)

View →

Apr 30, 2026May 4 9:36 PMRubenstein David M.Director
Option Exercise
8,116—0(D)

View →

Apr 30, 2026May 4 9:25 PMAbbas HussainDirector
Option Exercise
16,233—0(D)

View →

Apr 30, 2026May 4 8:59 PMElizabeth G NabelDirector
Option Exercise
16,233—0(D)

View →

Apr 30, 2026May 4 8:48 PMFrancois NaderDirector
Option Exercise
12,174—0(D)

View →

Apr 30, 2026May 4 8:44 PMElizabeth E TallettDirector
Option Exercise
4,058—0(D)

View →

Apr 2, 2026Apr 6 8:45 PMJames M MockChief Financial Officer
Option Exercise
1,453—2,906(D)

View →

Mar 5, 2026Mar 6 9:24 PMShannon Thyme KlingerChief Legal Officer
Option Exercise
11,797—129,774(D)

View →

Mar 5, 2026Mar 6 9:21 PMJames M MockChief Financial Officer
Option Exercise
11,797—129,774(D)

View →

Mar 1, 2026Mar 3 9:19 PMStephane BancelDirector, Chief Executive Officer
Grant/Award
250,932$53.57250,932(D)

View →

Mar 1, 2026Mar 3 9:14 PMStephen HogePresident
Grant/Award
290,696$53.57165,230(D)

View →

Feb 27, 2026Mar 3 9:14 PMStephen HogePresident
Option Exercise
39,830—111,393(D)

View →

Mar 2, 2026Mar 3 9:10 PMShannon Thyme KlingerChief Legal Officer
Option Exercise
13,885$30.9641,658(D)

View →

Mar 1, 2026Mar 3 9:10 PMShannon Thyme KlingerChief Legal Officer
Grant/Award
67,828$53.5738,553(D)

View →

Feb 27, 2026Mar 3 9:10 PMShannon Thyme KlingerChief Legal Officer
Option Exercise
9,999—25,992(D)

View →